NCT06308354|Recruiting
Loading search results
Sponsor study identifier
observational
40,000
1 country
1
Study Start
January 1, 2011
Actual (reported)Primary Completion
January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2011
Actual (reported)February 18, 2024
Actual (reported)March 13, 2024
Actual (reported)January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
overall survival
to dead or lost to follow
from date of diagnosis until the date of death from any cause, assessed up to 120 months
DFS
disease-free survival
from date of diagnosis until the first documented progression or recurrence, assessed up to 120 months
Colorectal cancer patients are enrolled when patients were underwent surgeries.
Colorectal cancer patients mainly comes from the western areas of China, and would accept the surgical procedures. Participate would be followed up every 6 months after surgery.
Fourth Military Medical University
Xi'an, Shaanxi, China
Cao S, Qiao Y, Wu L, Chen Q, Tian K, Li J, Xing C. Postoperative adjuvant chemotherapy in patients with stage II early onset colorectal cancer: exploration and discovery using real-world data and the SEER database. Front Oncol. 2025 May 30;15:1566569. doi: 10.3389/fonc.2025.1566569. eCollection 2025.
First Submitted
February 18, 2024
First Posted
March 13, 2024
Study Start
January 1, 2011
Actual (reported)Primary Completion
January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Contact the study team to confirm eligibility.
Study Completion
January 1, 2048
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 13, 2024
Record last verified: 2024-01
The investigators aim to explore the clinical characteristics of colorectal cancer patients in the Xijing hospital.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: